ERBB2 and ovarian carcinoma: Overexpression of HER2 is an adverse prognostic factor in breast 14, gastric 34, pancreatic 35, lung 36, and ovarian carcinomas 13 and we previously reported that high-level expression of the transcription factor GATA4 is associated with more aggressive GCTs 27.